FDA
approval
· 2024-10-18
FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Biocon Pharma Inc.)
Summary
FDA approved Biocon Pharma Inc.'s supplemental application for Labetalol Hydrochloride, a generic beta-blocker used to treat hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)